0001478242-21-000015.txt : 20210211
0001478242-21-000015.hdr.sgml : 20210211
20210211174044
ACCESSION NUMBER: 0001478242-21-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210211
DATE AS OF CHANGE: 20210211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAUB W RICHARD
CENTRAL INDEX KEY: 0001181162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35907
FILM NUMBER: 21621241
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IQVIA HOLDINGS INC.
CENTRAL INDEX KEY: 0001478242
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 271341991
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-998-2000
MAIL ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc.
DATE OF NAME CHANGE: 20161003
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc.
DATE OF NAME CHANGE: 20091208
4
1
wf-form4_161308321647666.xml
FORM 4
X0306
4
2021-02-09
0
0001478242
IQVIA HOLDINGS INC.
IQV
0001181162
STAUB W RICHARD
C/O IQVIA HOLDINGS INC.
4820 EMPEROR BLVD.
DURHAM
NC
27703
0
1
0
0
See Remarks
Common Stock
2021-02-09
4
A
0
9800
0
A
22270
D
Common Stock
2021-02-09
4
A
0
2407
0
A
24677
D
Common Stock
2021-02-09
4
F
0
3583
183.82
D
21094
D
Stock Appreciation Right
183.82
2021-02-09
4
A
0
9612
0
A
2031-02-09
Common Stock
9612.0
9612
D
Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 8, 2018. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2021.
Represents a grant of restricted stock units that will vest in three annual installments beginning on February 9, 2022.
This stock appreciation right vests in three annual installments beginning on February 9, 2022.
President, Research & Development Solutions
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub
2021-02-11